Patent · US Active

IRAK4 inhibiting agents

US10246456B2 · kind B2 · utility

3Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 2015
Grant dateApr 2, 2019
Priority date—
Expiry dateJul 17, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.